News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,045 Results
Type
Article (55306)
Company Profile (482)
Press Release (698257)
Section
Business (218452)
Career Advice (2856)
Deals (37452)
Drug Delivery (114)
Drug Development (86866)
Employer Resources (181)
FDA (17116)
Job Trends (15981)
News (370270)
Policy (35686)
Tag
Academia (2904)
Alliances (53657)
Alzheimer's disease (1396)
Approvals (17051)
Artificial intelligence (200)
Bankruptcy (383)
Best Places to Work (12287)
Biotechnology (358)
Breast cancer (225)
Cancer (1677)
Cardiovascular disease (138)
Career advice (2391)
CAR-T (121)
Cell therapy (350)
Clinical research (69392)
Collaboration (651)
Compensation (318)
COVID-19 (2785)
C-suite (152)
Data (1537)
Diabetes (208)
Diagnostics (6608)
Earnings (88266)
Employer resources (157)
Events (119419)
Executive appointments (541)
FDA (17947)
Funding (570)
Gene therapy (252)
GLP-1 (734)
Government (4810)
Healthcare (20167)
Infectious disease (2888)
Inflammatory bowel disease (128)
Interviews (550)
IPO (17084)
Job creations (4164)
Job search strategy (1979)
Layoffs (486)
Legal (8772)
Lung cancer (250)
Manufacturing (239)
Medical device (13950)
Medtech (13955)
Mergers & acquisitions (20646)
Metabolic disorders (572)
Neuroscience (1812)
NextGen: Class of 2025 (7260)
Non-profit (4910)
Northern California (1950)
Obesity (328)
Opinion (239)
Patents (146)
People (61974)
Phase I (21619)
Phase II (30457)
Phase III (22686)
Pipeline (646)
Postmarket research (2950)
Preclinical (9335)
Radiopharmaceuticals (258)
Rare diseases (324)
Real estate (6569)
Regulatory (23839)
Research institute (2596)
Resumes & cover letters (453)
Southern California (1696)
Startups (3926)
United States (17903)
Vaccines (659)
Weight loss (245)
Date
Today (108)
Last 7 days (621)
Last 30 days (2580)
Last 365 days (36755)
2025 (2550)
2024 (37219)
2023 (41999)
2022 (53335)
2021 (58009)
2020 (56780)
2019 (50016)
2018 (37828)
2017 (34906)
2016 (34803)
2015 (40904)
2014 (35079)
2013 (30509)
2012 (32437)
2011 (32874)
2010 (31160)
Location
Africa (920)
Arizona (222)
Asia (42979)
Australia (7773)
California (4533)
Canada (1616)
China (384)
Colorado (202)
Connecticut (227)
Europe (96046)
Florida (636)
Georgia (155)
Illinois (470)
Indiana (258)
Maryland (743)
Massachusetts (3539)
Michigan (196)
Minnesota (338)
New Jersey (1272)
New York (1287)
North Carolina (902)
Northern California (1950)
Ohio (163)
Pennsylvania (1036)
South America (1315)
Southern California (1696)
Texas (669)
Utah (131)
Washington State (460)
754,045 Results for "windtree therapeutics inc formerly known as discovery laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery
January 23, 2025
·
3 min read
Press Releases
Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline
January 9, 2025
·
6 min read
Policy
Windtree Therapeutics Regains Compliance with Nasdaq - May 07, 2024
Windtree Therapeutics, Inc. announced it has received a Bid Price Compliance Letter from The Nasdaq Stock Market LLC informing Windtree that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550 for continued listing on The Nasdaq Capital Market.
May 7, 2024
·
5 min read
Press Releases
Quantum Computing, Inc. Announces Collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute To Support Research Using Dirac-3 Systems
January 15, 2025
·
4 min read
Deals
Windtree Therapeutics Announces Reverse Stock Split - April 18, 2024
Windtree Therapeutics, Inc. today announced that the Company’s Board of Directors has approved a 1-for-18 reverse stock split of its issued and outstanding common stock, par value of $0.001 per share (the “Reverse Stock Split”).
April 18, 2024
·
7 min read
Deals
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
Windtree Therapeutics, Inc. today announced that it has engaged Ladenburg Thalmann & Co. Inc. (“Ladenburg”) to evaluate strategic alternatives for the Company with the goal of maximizing stockholder value.
January 31, 2024
·
6 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors
January 13, 2025
·
5 min read
1 of 75,405
Next
